Gene Therapy: An Historical Overview for Familial Hearing Loss.

Area of Science:

• Biomedical Sciences
• Genetics
• Otolaryngology

Background:

• Gene therapy offers a molecular strategy for managing inherited hearing loss.
• The concept is rooted in genetic determinism, linking specific genes to traits.
• Past successes in simple assays may not translate to complex human diseases.

Purpose of the Study:

• To examine the scientific basis of genetic determinism in hearing loss.
• To evaluate the current state and readiness of gene therapy for clinical use in hearing loss.
• To address the challenges and ethical considerations surrounding gene therapy for hearing loss.

Main Methods:

• Literature review across biomedical sciences.
• Analysis of molecular biologic premises for gene therapy.
• Critical appraisal of current gene therapy research and claims.

Main Results:

• The foundation for gene therapy relies on simplified biological models.
• Commercial and academic interests may overshadow scientific rigor in gene therapy development.
• Significant unresolved issues regarding safety, efficacy, and ethics persist.

Conclusions:

• Current gene therapy for hearing loss faces substantial safety, efficacy, and ethical hurdles.
• The ambitious claims require critical evaluation by scientists, clinicians, and patients.
• Gene therapy is not yet ready for routine integration into clinical practice for hearing loss management.